周一盘中，东瑞制药（02348）股价大跌6.98%，投资者对公司最新公布的中期业绩表现失望。
根据公司公告，东瑞制药2025年上半年业绩出现明显下滑。公司报告期内实现收入约6.3亿元人民币，同比下降9.2%。更值得注意的是，公司净利润仅为1.05亿元人民币，同比大幅下滑78.8%。每股盈利降至0.06961元人民币，相比去年同期出现显著下降。
尽管业绩表现不佳，东瑞制药仍维持派发中期股息0.015港元。然而，这似乎未能安抚投资者的情绪。分析人士指出，公司业绩的大幅下滑可能反映了其面临的市场竞争加剧和成本上升等挑战。市场将密切关注公司下半年的业务表现，以及管理层针对当前困境所采取的应对措施。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.